X0202 SCHEDULE 13D/A 0001829126-26-009359 0001200461 XXXXXXXX LIVE 9 Common Stock 09/11/2026 false 0001822523 00109K105 Advanced Flower Capital Inc.

477 S. Rosemary Ave., Suite 301 West Palm Beach FL 33401

Leonard M. Tannenbaum (561) 510-2390 477 S. Rosemary Ave, Suite 301 West Palm Beach FL 33401 0001200461 N Leonard M. Tannenbaum PF OO N X1 6924497.00 180400.00 6924497.00 180400.00 7104897.00 N 31.6 IN This Amendment No. 9 to Schedule 13D (this "Amendment No. 9") amends and supplements the Schedule 13D originally filed with the Securities and Exchange Commission (the "SEC") by Leonard M. Tannenbaum (the "Reporting Person") with respect to Advanced Flower Capital Inc. (the "Issuer") on April 2, 2021 (the "Schedule 13D"), as amended by Amendment No. 1 to Schedule 13D filed on July 2, 2024, Amendment No. 2 to Schedule 13D filed on August 26, 2025, Amendment No. 3 to Schedule 13D filed on August 29, 2025, Amendment No. 4 to Schedule 13D filed on November 24, 2025, Amendment No. 5 to Schedule 13D filed on March 11, 2026, Amendment No. 6 to Schedule 13D filed on March 24, 2026, Amendment No. 7 to Schedule 13D filed on June 18, 2026 and Amendment No. 8 to Schedule 13D filed on August 26, 2026. This Amendment No. 9 is being filed to report changes in the Reporting Person's beneficial ownership of the Issuer's common stock, par value $0.01 per share (the "Common Stock"). Since the filing of the Reporting Person's most recent Schedule 13D/A, the Reporting Person has acquired additional shares of the Issuer's Common Stock that resulted in an increase in the Reporting Person's beneficial ownership by more than one percent (1%) of the outstanding shares of the Issuer's Common Stock. As the aggregate result of the transactions described herein, the Reporting Person's aggregate beneficial ownership of the Issuer's Common Stock has increased by approximately 1.2 percentage points since the filing of the most recent Schedule 13D/A. The Schedule 13D is hereby amended and supplemented to include the information set forth herein. Capitalized terms not defined herein have the meanings given to such terms in the Schedule 13D. Except as set forth herein, the Schedule 13D is unmodified. Lines 7 and 9 consist of 6,924,497 shares of the Issuer's Common Stock held directly by the Reporting Person. Lines 8 and 10 consist of 180,400 shares of Common Stock held by the Tannenbaum Family Foundation (formerly known as the Leonard M. Tannenbaum Foundation), for which the Reporting Person serves as the President, over which the Reporting Person disclaims beneficial ownership, except to the extent of his pecuniary interest. The Schedule 13D excludes 226,907 shares of Common Stock held by Ms. Robyn Tannenbaum, the Reporting Person's spouse, over which the Reporting Person disclaims beneficial ownership. Line 13 is based on the 22,468,755 shares of Common Stock outstanding as of September 14, 2026, as reported in the Issuer's Form 8-K, filed with the SEC on September 15, 2026. Common Stock Advanced Flower Capital Inc. 477 S. Rosemary Ave., Suite 301 West Palm Beach FL 33401 Item 3 of the Schedule 13D is hereby amended and supplemented by the addition of the following information: Since August 26, 2026, the Reporting Person purchased shares of Common Stock in multiple open market transactions using personal funds, as listed on Schedule A, attached hereto, and incorporated herein. In addition, this Amendment No. 9 is being filed to reflect increases in the percentage of outstanding Common Stock of the Issuer beneficially owned by the Reporting Person as a result of repurchases of shares of Common Stock made by the Issuer in the open market in the period from August 26, 2026 to September 14, 2026, under the Issuer's share repurchase program authorized by the Board of Directors of the Issuer. See Items 7-11 and 13 of the cover page above and Item 3. See Items 7-11 and 13 of the cover page above and Item 3. Transactions in the Common Stock since the last Schedule 13D/A filing are set forth in Schedule A and are incorporated herein. Other than those transactions listed on Schedule A, no transactions in the shares of Common Stock have been effected by the Reporting Person since the filing of Amendment No. 8 to Schedule 13D on August 26, 2026. Ex 99.1 - Schedule A - Attached here. Leonard M. Tannenbaum /s/ Leonard M. Tannenbaum 09/15/2026